Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. [electronic resource]
Producer: 20080116Description: 2445-53 p. digitalISSN:- 1473-5571
- Adult
- Alkynes
- Anthropometry
- Anti-HIV Agents -- adverse effects
- Antiretroviral Therapy, Highly Active -- adverse effects
- Benzoxazines -- adverse effects
- Body Constitution
- Cardiovascular Diseases -- chemically induced
- Cyclopropanes
- Diabetes Mellitus, Type 2 -- chemically induced
- Disease Progression
- Epidemiologic Methods
- Female
- HIV Infections -- drug therapy
- Humans
- Male
- Metabolic Syndrome -- chemically induced
- Middle Aged
- Nelfinavir -- adverse effects
- Reverse Transcriptase Inhibitors -- adverse effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.